Levi & Korsinsky is investigating the Board of Directors of Durata
Therapeutics Inc. (“Durata” or “the Company”) (NASDAQ: DRTX) for
possible breaches of fiduciary duty and other violations of state law in
connection with the sale of the Company to Actavis (NYSE:ACT).
Click here to learn more about the investigation: http://zlk.9nl.com/durata-therapeutics-drtx .
for - INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Durata Therapeutics Inc. Concerning the Fairness of the Sale of the Company to Actavis investment picks